Milestone Fee. Within: (a) 30 days after the achievement of a Clinical and Regulatory Milestone; and (b) 30 days after the achievement of a Commercial Milestone, Cortendo must pay to ATL the applicable Milestone Fee.
Appears in 3 contracts
Sources: Technology Licence Agreement (Strongbridge Biopharma PLC), Technology Licence Agreement (Cortendo AB), Technology Licence Agreement (Cortendo AB)